GRIA2 and Alzheimer disease: Inhibition of miR‐181a effectively reverses Aβo‐induced impairments in plasticity and memory deficits in primary hippocampal cultures and 3xTg‐AD mice through restoration of GluA2 and GluA1 protein levels in the hippocampus.